Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury

References

• Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update a report from the American Heart Association. Circulation. 2018;137(12):143–152. doi:10.1161/cir.0000000000000558
   Web of Science ®Google Scholar
• Wan L, Cheng YF, Luo ZY, et al. Neuroprotection, learning and memory improvement of a standardized extract from Renshen Shouwu against neuronal injury and vascular dementia in rats with brain ischemia. J Ethnopharmacol. 2015;165:118–126. doi:10.1016/j.jep.2015.02.02725704930
   PubMed Web of Science ®Google Scholar
• CK N, RT L, MD B. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015;72:3. doi:10.1001/jamaneurol.2014.3558
   Web of Science ®Google Scholar
• Dirnagl U, Lindauer U, Them A, et al. Global cerebral-ischemia in the rat – online monitoring of oxygen-free radical production using chemiluminescence in-vivo. J Cereb Blood Flow Metab. 1995;15(6):929–940. doi:10.1038/jcbfm.1995.1187593353
   PubMed Web of Science ®Google Scholar
• Cao YG, Mao XY, Sun CY, et al. BA attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways. Brain Res Bull. 2011;85(6):396–402. doi:10.1016/j.brainresbull.2011.05.00221600966
   PubMed Web of Science ®Google Scholar
• Wang PQ, Liu Q, Xu WJ, et al. Pure mechanistic analysis of additive neuroprotective effects between BA and jasminoidin in ischemic stroke mice. Acta Pharmacol Sin. 2018;39(6):961–974. doi:10.1038/aps.2017.14529345255
   PubMed Web of Science ®Google Scholar
• Dai J, Chen L, Qiu YM, et al. Activations of gabaergic signaling, HSP70 and MAPK cascades are involved in BA’s neuroprotection against gerbil global ischemia/reperfusion injury. Brain Res Bull. 2013;90:1–9. doi:10.1016/j.brainresbull.2012.09.01423041106
   PubMed Web of Science ®Google Scholar
• Grossi C, Guccione C, Isacchi B, et al. Development of blood-brain barrier permeable nanoparticles as potential carriers for salvianolic acid b to CNS. Planta Med. 2017;83(5):382–391. doi:10.1055/s-0042-10194527002395
   PubMed Web of Science ®Google Scholar
• Li JX, Zhang M, Chao JB, et al. Preparation and characterization of the inclusion complex of BA (bg) with beta-cd and hp-beta-cd in solution: an antioxidant ability study. Spectroc Acta Pt A-Molec Biomolec Spectr. 2009;73(4):752–756. doi:10.1016/j.saa.2009.03.025
   PubMed Web of Science ®Google Scholar
• Li N, Ye YJ, Yang M, et al. Pharmacokinetics of BA-phospholipid complex in rat plasma and brain tissues after intranasal and intravenous administration. Pharmazie. 2011;66(5):374–377. doi:10.1691/ph.2011.078321699072
   PubMed Web of Science ®Google Scholar
• Bhatia SP, Letizia CS, Api AM. Fragrance material review on borneol. Food Chem Toxicol. 2008;46(11):77–80. doi:10.1016/j.fct.2008.06.031
   Google Scholar
• Chen ZX, Xu QQ, Shan CS, et al. Borneol for regulating the permeability of the blood-brain barrier in experimental ischemic stroke: preclinical evidence and possible mechanism. Oxidative Med Cell Longev. 2019;2019:15. doi:10.1155/2019/2936737
   Web of Science ®Google Scholar
• Tambe R, Jain P, Patil S, et al. Antiepileptogenic effects of borneol in pentylenetetrazole-induced kindling in mice. Naunyn-Schmiedebergs Arch Pharmacol. 2016;389(5):467–475. doi:10.1007/s00210-016-1220-z26887325
   PubMed Web of Science ®Google Scholar
• Yu B, Ruan M, Zhang ZN, et al. Synergic effect of borneol and ligustrazine on the neuroprotection in global cerebral ischemia/reperfusion injury: a region-specificity study. Evid-Based Complement Altern Med. 2016;8:1–8. doi:10.1155/2016/4072809
   Google Scholar
• Cai Z, Hou SX, Li YB, et al. Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration. J Drug Target. 2008;16(2):178–184. doi:10.1080/1061186070179439518274938
   PubMed Web of Science ®Google Scholar
• Tang SN, Wang AP, Yan XJ, et al. Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating parkinson’s disease. Drug Deliv. 2019;26(1):700–707. doi:10.1002/bmc.65531290705
   PubMed Web of Science ®Google Scholar
• Wu JY, Li YJ, Yang L, et al. Borneol and asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors. Drug Deliv. 2018;25(1):1858–1864. doi:10.1080/10717544.2018.151600530338713
   PubMed Web of Science ®Google Scholar
• Li M-H, Ruan L-Y, Chen C, et al. Protective effects of polygonum multiflorum on ischemic stroke rat model analysed by 1 H NMR metabolic profiling. J Pharm Biomed Anal. 2018;155:91–103. doi:10.1016/j.jpba.2018.03.04929625260
   PubMed Web of Science ®Google Scholar
• Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral-artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84–91. doi:10.1161/01.Str.20.1.842643202
   PubMed Web of Science ®Google Scholar
• Li N, Feng LL, Tan YJ, et al. Preparation, characterization, pharmacokinetics and biodistribution of BA-loaded liposome on cerebral ischemia-reperfusion after i.v. administration in rats. Molecules. 2018;23(7):15. doi:10.3390/molecules23071747
   Web of Science ®Google Scholar
• Lv ZY, Yang YW, Wang J, et al. Optimization of the preparation conditions of borneol-modified ginkgolide liposomes by response surface methodology and study of their blood brain barrier permeability. Molecules. 2018;23(2):15. doi:10.3390/molecules23020303
   Web of Science ®Google Scholar
• Wu Y, Wang SJ, Shang L, et al. Effect of borneol as a penetration enhancer on brain targeting of nanoliposomes: facilitate direct delivery to neurons. Nanomedicine. 2018;13(21):2709–2727. doi:10.2217/nnm-2018-028230234427
   PubMed Web of Science ®Google Scholar
• Ahmad N, Al-Subaiec AM, Ahmad R, et al. Brain-targeted glycyrrhizic-acid-loaded surface decorated nanoparticles for treatment of cerebral ischaemia and its toxicity assessment. Artif Cell Nanomed Biotechnol. 2019;47(1):475–490. doi:10.1080/21691401.2018.1561458
   PubMed Web of Science ®Google Scholar
• Tang YH, Zhang HY, Zhao YY, et al. Determination of human plasma protein binding of BA by ultrafiltration and high-performance liquid chromatography. Biomed Chromatography. 2006;20(10):1116–1119. doi:10.1002/bmc.655
   PubMed Web of Science ®Google Scholar
• Huang T, Liu YA, Zhang CL. Pharmacokinetics and bioavailability enhancement of BA: a review. Eur J Drug Metabol Pharmacokinet. 2019;44(2):159–168. doi:10.1007/s13318-018-0509-3
   PubMed Web of Science ®Google Scholar
• Mandpe P, Prabhakar B, Shende P. Role of liposomes-based stem cell for multimodal cancer therapy. Stem Cell Rev Rep. 2020;16(1):103–117. doi:10.1007/s12015-019-09933-z31786749
   PubMed Web of Science ®Google Scholar
• Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154(2):123–140. doi:10.1016/s0378-5173(97)00135-x
   Web of Science ®Google Scholar
• Almeida J, Souza GR, Silva JC, et al. Borneol, a bicyclic monoterpene alcohol, reduces nociceptive behavior and inflammatory response in mice. Sci World J. 2013:5. doi:10.1155/2013/808460.
   Google Scholar
• Bin Y, Ming R, Zhen-Nian Z, et al. Synergic effect of borneol and ligustrazine on the neuroprotection in global cerebral ischemia/reperfusion injury: a region-specificity study. Evid Based Complement Alternat Med. 2016;2016:1–8. doi:10.1155/2016/4072809
   Web of Science ®Google Scholar
• Kong Q, Wu Z, Chu X, et al. Study on the anti-cerebral ischemia effect of borneol and its mechanism. African J Traditional Complementary Alternative Med Ajtcam. 2013;11:1. doi:10.4314/ajtcam.v11i1.25
   PubMedGoogle Scholar
• Zhang HY, Lai Q, Li Y, et al. Learning and memory improvement and neuroprotection of Gardenia jasminoides (Fructus gardenia) extract on ischemic brain injury rats. J Ethnopharmacol. 2017;196:225–235. doi:10.1016/j.jep.2016.11.04227940085
   PubMed Web of Science ®Google Scholar
• SM S, AP N, MD K, et al. Brain hypoxia secondary to diffusion limitation in hypoxic ischemic brain injury postcardiac arrest. Crit Care Med. 2020;48:3. doi:10.1097/CCM.000000000000413831841450
   PubMed Web of Science ®Google Scholar
• Guan QH, Pei DS, Liu XM, et al. Neuroprotection against ischemic brain injury by sp600125 via suppressing the extrinsic and intrinsic pathways of apoptosis. Brain Res. 2006;1092:36–46. doi:10.1016/j.brainres.2006.03.08616674927
   PubMed Web of Science ®Google Scholar
• Zhi Z, Mengdi G, Ying L, et al. RNPS1 inhibition aggravates ischemic brain injury and promotes neuronal death. Biochem Biophys Res Commun. 2020;523(1):39–45. doi:10.1016/j.bbrc.2019.11.18531831174
   PubMed Web of Science ®Google Scholar
• Zeng CS, Wang DS, Chen C, et al. Zafirlukast protects blood-brain barrier integrity from ischemic brain injury. Chem-Biol Interact. 2020;316:6. doi:10.1016/j.cbi.2019.108915
   Web of Science ®Google Scholar
• Lin RH, Lin YK, Tao J, et al. Electroacupuncture ameliorates learning and memory in rats with cerebral ischemia-reperfusion injury by inhibiting oxidative stress and promoting p-CREB expression in the hippocampus. Mol Med Rep. 2015;12(5):6807–6814. doi:10.3892/mmr.2015.432126397995
   PubMed Web of Science ®Google Scholar
• Dong TW, Chen N, Ma X, et al. The protective roles of l-borneolum, d-borneolum and synthetic borneol in cerebral ischaemia via modulation of the neurovascular unit. Biomed Pharmacother. 2018;102:874–883. doi:10.1016/j.biopha.2018.03.08729728011
   PubMed Web of Science ®Google Scholar